Elaine Paul has risen to the top of a predominantly male financial industry as the CFO of Hulu. She sits down with Alyssa Julya Smith in Los Angeles to talk about her impressive career.
Prior to heading up a 100 person team at Hulu, Paul served as Senior Vice President of Corporate Strategy at the Walt Disney Company, where she led various acquisitions, new business initiatives, and strategic investments, including Disney’s original investment in Hulu in 2009.
Paul also discusses the network's dedication to creating female empowering content like "The Handmaid's Tale" and what goes into the financial decisions behind what type of content to invest in as a company. Finally, as a female executive she speaks passionately about creating a good balance in her life, both for herself and other women who are struggling with "doing it all."
Kim Kardashian’s shapewear brand Skims has doubled its valuation to $3.2 billion. Investors have taken a bet on the success of this brand in the form of fresh funds for the two-year-old company.
McDonald's missed on both the top and bottom lines in its Q4 earnings, marking the fourth loss for the fast-food giant in the past eight quarters. It comes as higher costs from food to wages ate into the blue-chip company's profits. George Seay, CEO of investment advisor Annandale Capital, joined Wake Up with Cheddar to discuss the recent numbers and the better-than-expected success of the McPlant burger made with plant-based Beyond Meat. "They're changing with the times, and they have to," Seay noted. "You can just sell a Big Mac to everybody. There's a lot of people who don't want to eat a Big Mac anymore."
Moderna launched a clinical trial of a COVID-19 booster shot specifically targeting the omicron variant. The first participant has already received a dose, and Moderna expects to enroll about 600 adults total, split between two groups. In the first group, participants will have previously received two doses of the Moderna vaccine, and in the second, participants will have received its booster. Dr. Paul Burton, chief medical officer at Moderna, joined Cheddar’s Opening Bell to discuss the trial, yearly boosters, and what lies ahead for the company.
